| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/09/2013 | CN102869779A Pharmacologically induced transgene ablation system |
| 01/09/2013 | CN102869777A Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3 |
| 01/09/2013 | CN102869776A Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF |
| 01/09/2013 | CN102869774A Compositions for targeted delivery of sirna |
| 01/09/2013 | CN102869386A AntimiR-451 for the treatment of polycythemias |
| 01/09/2013 | CN102869385A Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 01/09/2013 | CN102869383A DNA dendrimers as thermal ablation devices |
| 01/09/2013 | CN102864171A Lentiviral expression vector for specifically promoting high expression of CYP3A4 (cytochrome P450 3A4) gene in hepatocytes, and construction method and application thereof |
| 01/09/2013 | CN102864150A Nucleic acid aptamer capable of recognizing HCV NS5A protein, and derivatives, screening method and application thereof |
| 01/09/2013 | CN102864149A Rat microRNAs (miRNAs) related to nerve proliferation functions, corresponding precursors and antisense oligonucleotide of miRNAs, and application |
| 01/09/2013 | CN102864148A Rat source miRNA related with nerve migration function, corresponding miRNA precursor, antisense oligonucleotide and application of antisense oligonucleotide |
| 01/09/2013 | CN102864147A Six rat microRNAs (miRNAs) related to nerve proliferation and migration functions, corresponding precursors and antisense oligonucleotide of miRNAs, and application |
| 01/09/2013 | CN102863538A Fused polypeptide mutant containing protein transduction domain and preparation method thereof |
| 01/09/2013 | CN102863537A Tumor targeting tumor necrosis factor related apoptosis ligand variant and application thereof |
| 01/09/2013 | CN102863515A B-cell epitope of human melanoma antigen MAGE-A3 and application thereof |
| 01/09/2013 | CN102863514A Peptide vaccines for cancers expressing tumor-associated antigens |
| 01/09/2013 | CN102863026A Water-dispersible manganese-doped magnetic nano-cluster, and preparation method and application thereof |
| 01/09/2013 | CN102861343A Application of secretory type Klotho in preparing medicine for treating chronic renal failure |
| 01/09/2013 | CN102861341A Composite nano-carrier capable of loading nucleic acid drugs efficiently and preparation method of composite nano-carrier |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102226203B Construction and application of dual shRNA expression plasmid of dual chU6 promoter |
| 01/09/2013 | CN102199611B Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof |
| 01/09/2013 | CN102161998B Deoxyribonucleic acid (DNA) vaccine based on B7-1-PE40KDEL exotoxin fusion gene and application thereof |
| 01/09/2013 | CN102008735B Small molecular DNA vaccine and preparation method thereof |
| 01/09/2013 | CN101824424B DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof |
| 01/08/2013 | US8350021 Inhibiting expression of a polynucleotide sequence of hepatitis B virus and hepatitis C virus; mammalian cell comprising an expression construct; vectors |
| 01/08/2013 | US8349810 Methods for targeted cleavage and recombination of CCR5 |
| 01/08/2013 | US8349807 Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody |
| 01/08/2013 | US8349607 Gene silencing |
| 01/08/2013 | US8349606 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 01/08/2013 | US8349364 Nucleic acid coated particles suitable for temporary storage |
| 01/08/2013 | US8349292 Treatment of allergic otitis media in mammals with Clostridia neurotoxins |
| 01/08/2013 | CA2677176C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 01/08/2013 | CA2660153C Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 01/08/2013 | CA2563388C Microrna and methods for inhibiting same |
| 01/08/2013 | CA2558771C Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 01/08/2013 | CA2536333C Interfering rna duplex having blunt-ends and 3'-modifications |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2485882C A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient |
| 01/08/2013 | CA2409873C Hcv variants |
| 01/08/2013 | CA2388337C Method of inducing and/or enhancing an immune response to tumor antigens |
| 01/08/2013 | CA2385498C Method to enhance healing of sternum after sternotomy |
| 01/08/2013 | CA2377207C Combinations for introducing nucleic acids into cells |
| 01/08/2013 | CA2341777C Neutral amino acid transporter and gene thereof |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/08/2013 | CA2299630C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/03/2013 | WO2013003801A2 Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction |
| 01/03/2013 | WO2013003557A1 Photoactivatable receptors and their uses |
| 01/03/2013 | WO2013003346A2 Microrna-31 compositions and methods for use in autoimmune disease |
| 01/03/2013 | WO2013002733A1 Pharmaceutical compositions for treating cancer |
| 01/03/2013 | WO2013001130A1 Lrp1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (vldl) to ischaemic cardiac muscle |
| 01/03/2013 | WO2013000064A1 Alternative splicing modulators and splice variants and their use in the control and detection of pluripotency and differentiation |
| 01/03/2013 | WO2012156817A9 Method for treating non-small cell lung cancer |
| 01/03/2013 | WO2012149472A9 Methods, compositions, and kits for treating and preventing neurological conditions |
| 01/03/2013 | WO2012149024A3 Dna aptamers for promoting remyelination |
| 01/03/2013 | WO2012134234A3 Use of hades as a negative modulator of akt |
| 01/03/2013 | WO2012129394A3 Methods and compositions for the treatment of cancer |
| 01/03/2013 | WO2012012546A3 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/03/2013 | WO2011141705A8 Novel cationic lipids and methods of use thereof |
| 01/03/2013 | WO2009095796A3 Tapasin augmentation for enhanced immune response |
| 01/03/2013 | US20130005797 Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides |
| 01/03/2013 | US20130005668 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130004562 Process for preparing purified nucleic acid and the use thereof |
| 01/03/2013 | US20130004470 p27 AND p21 IN GENE THERAPIES |
| 01/03/2013 | US20130004462 Modified factor viii and factor ix genes and vectors for gene therapy |
| 01/03/2013 | CA2839938A1 Photoactivatable receptors and their uses |
| 01/02/2013 | EP2539452A2 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 01/02/2013 | EP2539451A1 Compositions for targeted delivery of sirna |
| 01/02/2013 | EP2539448A1 Protein c zymogen and methods of use thereof to prevent cancer metastases |
| 01/02/2013 | EP2538977A1 Dna dendrimers as thermal ablation devices |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1551781B One dose vaccination with mycoplasma hyopneumoniae |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858979A Treatment Of Fibroblast Growth Factor 21 (FGF21) Related Diseases By Inhibition Of Natural Antisense Transcript To FGF21 |
| 01/02/2013 | CN102858376A Method For Proliferating Cardiomyocytes Using Micro-RNA |
| 01/02/2013 | CN102851350A Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 01/02/2013 | CN102851315A Application of recombinant adenovirus TMEM166 as gene therapeutic drug in inhibiting tumor |
| 01/02/2013 | CN102851293A Sequence siRNA-165 capable of targeted inhibition of capripoxvirus ORF095 gene |
| 01/02/2013 | CN102851292A siRNA sequences specifically silencing gI and gE gene of Marek's disease virus, and vector and preparation thereof |
| 01/02/2013 | CN102851291A Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 01/02/2013 | CN102850435A Peptide vaccines for cancers expressing MPHOSP1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850434A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102850433A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/02/2013 | CN102847172A Preparation method of genetic engineering vaccine for preventing staphylococcus caprae mastitis application |
| 01/02/2013 | CN102847171A Gene medicine for treating liver cancer and preparation method and application thereof |
| 01/02/2013 | CN102847170A Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 01/02/2013 | CN102847169A Megalocytivirus DNA (deoxyribonucleic acid) vaccine, as well as construction and application thereof |
| 01/02/2013 | CN102847168A Design and construction of nucleic acid vaccine PV-Fn for preventing cow mastitis |
| 01/02/2013 | CN102847167A Construction of improved synergetic nucleic acid vaccine for preventing cow mastitis |
| 01/02/2013 | CN102847154A Therapeutic uses of inhibitors of RTP801 |
| 01/02/2013 | CN102847150A Gene target of aging control and application thereof |
| 01/02/2013 | CN102417907B SiRNA (small interfering RNA) sequences of targeted inhibition capripoxvirus ORF095 genes |
| 01/02/2013 | CN102268446B Tubercle bacillus Ag85ab mosaic gene vaccine and preparation method and application thereof |
| 01/02/2013 | CN102242116B Cytoskeletal binding protein siRNA (small interfering ribonucleic acid) interfering sequence, fusion expression vector thereof and medical application of same |
| 01/02/2013 | CN102178929B Application of ancylostoma caninum anticoagulant peptide (AcAP) and recombinant thereof in preparation of thrombus dissolving medicaments |
| 01/02/2013 | CN102174520B Interference nucleic acid molecule and application thereof |
| 01/02/2013 | CN102146411B Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament |
| 01/02/2013 | CN102070704B Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
| 01/02/2013 | CN102038960B Method for preparing outer membrane protein H and A genes of fowl cholera and fused DNA vaccine |